Days Speakers Session Type Search
Type

    13:10 - 13:55 
    Novo Nordisk Obesity sponsored Satellite Symposium
    This is a promotional meeting organised and funded by Novo Nordisk. Novo Nordisk products will be discussed at this meeting. Intended for GB-based healthcare professionals only.
    Novo Nordisk Obesity
    Queen’s Suite B
    Chair: Barbara McGowan

    13:15 - 14:15 
    Consilient Health sponsored Satellite Symposium
    How to diagnose and treat GH deficiency in adults
    Consilient Health
    Queen’s Suite B
    Consilient Health sponsored Satellite Symposium
    Introduction
    Birmingham, UK
    Consilient Health sponsored Satellite Symposium
    Pitfalls in the diagnosis of GH deficiency in adults
    Birmingham, United Kingdom
    Consilient Health sponsored Satellite Symposium
    How to follow up GH replacement in adults
    Leeds Teaching Hospitals NHS Trust, Leeds, UK
    Consilient Health sponsored Satellite Symposium
    The role of the nurse in the adult GH deficiency patient pathway
    Birmingham, UK
    Consilient Health sponsored Satellite Symposium
    Q&A
    Consilient Health sponsored Satellite Symposium
    Close
    13:15 - 14:15 
    HRA Pharma sponsored Satellite Symposium
    Challenge the Experts – Clinical Case Studies of Cushing’s Syndrome – Reloaded once more!
    HRA Pharma
    Queen’s Suite A
    Chair: John Newell-Price (Sheffield)
    HRA Pharma sponsored Satellite Symposium
    Welcome/Introduction's
    Sheffield, UK
    HRA Pharma sponsored Satellite Symposium
    Case 1
    HRA Pharma sponsored Satellite Symposium
    Case 2
    HRA Pharma sponsored Satellite Symposium
    Case 3
    HRA Pharma sponsored Satellite Symposium
    Summary and Q&A
    HRA Pharma sponsored Satellite Symposium
    Close
    Sheffield, UK

    12:15 - 13:15 
    BESINS sponsored Satellite Symposium
    Emerging evidence from trials in hypogonadism, and proposed plans for UK-wide testosterone assay harmonisation
    BESINS
    Queen's Suite B
    BESINS sponsored Satellite Symposium
    Introduction
    BESINS sponsored Satellite Symposium
    Cardiovascular safety outcomes from the testosterone efficacy & safety consortium (TestES)
    London, UK
    London, UK
    BESINS sponsored Satellite Symposium
    Emerging data from the T4DM study in normogonadal men with metabolic syndrome
    London, UK
    BESINS sponsored Satellite Symposium
    Proposed recommendations from the SfE Working Group on testosterone assay reporting and harmonisation.
    London, UK
    BESINS sponsored Satellite Symposium
    Close
    12:15 - 13:15 
    AMRYT Pharma sponsored Satellite Symposium
    Don’t miss this face in the crowd – suspect, recognise, refer and treat patients with lipodystrophy
    AMRYT Pharma
    Queen’s Suite A
    AMRYT Pharma sponsored Satellite Symposium
    Welcome & Introduction
    AMRYT Pharma sponsored Satellite Symposium
    When might you suspect a diagnosis of Generalised Partial Lipodystrophy and how is this confirmed?
    AMRYT Pharma sponsored Satellite Symposium
    MDT approach to the management of Generalised or Partial Liopdystrophy
    Cambridge
    Cambridge
    Cambridge
    AMRYT Pharma sponsored Satellite Symposium
    Q&A
    AMRYT Pharma sponsored Satellite Symposium
    Close
All faculty
Tue 15 13:20
HRA Pharma sponsored Satellite Symposium
Case 1
Tue 15 13:35
HRA Pharma sponsored Satellite Symposium
Case 2
Tue 15 13:50
HRA Pharma sponsored Satellite Symposium
Case 3
Wed 16 13:00
AMRYT Pharma sponsored Satellite Symposium
Q&A
Mr Sherwin Criseno
Birmingham, UK
Tue 15 13:50
Consilient Health sponsored Satellite Symposium
The role of the nurse in the adult GH deficiency patient pathway
Birmingham, UK
Catherine Flanagan
Cambridge
Wed 16 12:40
AMRYT Pharma sponsored Satellite Symposium
MDT approach to the management of Generalised or Partial Liopdystrophy
Cambridge
Cambridge
Cambridge
Lisa Gaff
Cambridge
Wed 16 12:40
AMRYT Pharma sponsored Satellite Symposium
MDT approach to the management of Generalised or Partial Liopdystrophy
Cambridge
Cambridge
Cambridge
Dr Helena Gleeson
Birmingham, United Kingdom
Tue 15 13:20
Consilient Health sponsored Satellite Symposium
Pitfalls in the diagnosis of GH deficiency in adults
Birmingham, United Kingdom
Channa Jayasena
London, UK
Wed 16 12:15
BESINS sponsored Satellite Symposium
Cardiovascular safety outcomes from the testosterone efficacy & safety consortium (TestES)
London, UK
London, UK
Wed 16 13:00
BESINS sponsored Satellite Symposium
Proposed recommendations from the SfE Working Group on testosterone assay reporting and harmonisation.
London, UK
Charlotte  Jenkins-Liu
Cambridge
Wed 16 12:40
AMRYT Pharma sponsored Satellite Symposium
MDT approach to the management of Generalised or Partial Liopdystrophy
Cambridge
Cambridge
Cambridge
Niki Karavitaki
Birmingham, UK
Tue 15 13:15
Consilient Health sponsored Satellite Symposium
Introduction
Birmingham, UK
Robert Murray
Leeds Teaching Hospitals NHS Trust, Leeds, UK
Tue 15 13:35
Consilient Health sponsored Satellite Symposium
How to follow up GH replacement in adults
Leeds Teaching Hospitals NHS Trust, Leeds, UK
John Newell-Price
Sheffield, UK
Tue 15 13:15
HRA Pharma sponsored Satellite Symposium
Welcome/Introduction's
Sheffield, UK
Tue 15 14:15
HRA Pharma sponsored Satellite Symposium
Close
Sheffield, UK
Richard Quinton
London, UK
Wed 16 12:15
BESINS sponsored Satellite Symposium
Cardiovascular safety outcomes from the testosterone efficacy & safety consortium (TestES)
London, UK
London, UK
Wed 16 12:35
BESINS sponsored Satellite Symposium
Emerging data from the T4DM study in normogonadal men with metabolic syndrome
London, UK
A Stears
Wed 16 12:20
AMRYT Pharma sponsored Satellite Symposium
When might you suspect a diagnosis of Generalised Partial Lipodystrophy and how is this confirmed?
Wed 16 12:40
AMRYT Pharma sponsored Satellite Symposium
MDT approach to the management of Generalised or Partial Liopdystrophy
Cambridge
Cambridge
Cambridge
Workshop 0
Oral 0
Expert 0
Plenary 0
Catering and Social 0
Nurse 0
Other 0
Symposium 5
Mon 14 13:10
Novo Nordisk Obesity sponsored Satellite Symposium
This is a promotional meeting organised and funded by Novo Nordisk. Novo Nordisk products will be discussed at this meeting. Intended for GB-based healthcare professionals only.
Novo Nordisk Obesity
Queen’s Suite B
Chair: Barbara McGowan
Tue 15 13:15
Consilient Health sponsored Satellite Symposium
How to diagnose and treat GH deficiency in adults
Consilient Health
Queen’s Suite B
Tue 15 13:15
Consilient Health sponsored Satellite Symposium
Introduction
Birmingham, UK
Tue 15 13:20
Consilient Health sponsored Satellite Symposium
Pitfalls in the diagnosis of GH deficiency in adults
Birmingham, United Kingdom
Tue 15 13:35
Consilient Health sponsored Satellite Symposium
How to follow up GH replacement in adults
Leeds Teaching Hospitals NHS Trust, Leeds, UK
Tue 15 13:50
Consilient Health sponsored Satellite Symposium
The role of the nurse in the adult GH deficiency patient pathway
Birmingham, UK
Tue 15 14:05
Consilient Health sponsored Satellite Symposium
Q&A
Tue 15 14:15
Consilient Health sponsored Satellite Symposium
Close
Tue 15 13:15
HRA Pharma sponsored Satellite Symposium
Challenge the Experts – Clinical Case Studies of Cushing’s Syndrome – Reloaded once more!
HRA Pharma
Queen’s Suite A
Chair: John Newell-Price (Sheffield)
Tue 15 13:15
HRA Pharma sponsored Satellite Symposium
Welcome/Introduction's
Sheffield, UK
Tue 15 13:20
HRA Pharma sponsored Satellite Symposium
Case 1
Tue 15 13:35
HRA Pharma sponsored Satellite Symposium
Case 2
Tue 15 13:50
HRA Pharma sponsored Satellite Symposium
Case 3
Tue 15 14:05
HRA Pharma sponsored Satellite Symposium
Summary and Q&A
Tue 15 14:15
HRA Pharma sponsored Satellite Symposium
Close
Sheffield, UK
Wed 16 12:15
BESINS sponsored Satellite Symposium
Emerging evidence from trials in hypogonadism, and proposed plans for UK-wide testosterone assay harmonisation
BESINS
Queen's Suite B
Wed 16 12:15
BESINS sponsored Satellite Symposium
Introduction
Wed 16 12:15
BESINS sponsored Satellite Symposium
Cardiovascular safety outcomes from the testosterone efficacy & safety consortium (TestES)
London, UK
London, UK
Wed 16 12:35
BESINS sponsored Satellite Symposium
Emerging data from the T4DM study in normogonadal men with metabolic syndrome
London, UK
Wed 16 13:00
BESINS sponsored Satellite Symposium
Proposed recommendations from the SfE Working Group on testosterone assay reporting and harmonisation.
London, UK
Wed 16 13:15
BESINS sponsored Satellite Symposium
Close
Wed 16 12:15
AMRYT Pharma sponsored Satellite Symposium
Don’t miss this face in the crowd – suspect, recognise, refer and treat patients with lipodystrophy
AMRYT Pharma
Queen’s Suite A
Wed 16 12:15
AMRYT Pharma sponsored Satellite Symposium
Welcome & Introduction
Wed 16 12:20
AMRYT Pharma sponsored Satellite Symposium
When might you suspect a diagnosis of Generalised Partial Lipodystrophy and how is this confirmed?
Wed 16 12:40
AMRYT Pharma sponsored Satellite Symposium
MDT approach to the management of Generalised or Partial Liopdystrophy
Cambridge
Cambridge
Cambridge
Wed 16 13:00
AMRYT Pharma sponsored Satellite Symposium
Q&A
Wed 16 13:15
AMRYT Pharma sponsored Satellite Symposium
Close
No Session Type 0

0 result(s) found.

Please wait...

     
      - 
     
     
     


    Abstracts from this event
      Abstracts from other events


          Session starts at:
          Abstract time:
        Event:


        Read full abstract